Clinical Trials 3538 Views Disappointing trial results from Modus Therapeutics Malin Otmani May 16, 2019 The company announces initial results …
Business article 3468 Views Company in focus: Modus Therapeutics Malin Otmani March 6, 2019 Swedish drug development company Modus …
Clinical Trials 2173 Views First cohort dosed in Modus Therapeutics study Malin Otmani March 6, 2019 The first cohort has been …
In a new job 2084 Views Modus Therapeutics appoints two new Board members Malin Otmani February 1, 2019 Modus Therapeutics strengthens its Board …
Clinical Trials 2106 Views Modus Therapeutics completes enrollment of Phase II study Malin Otmani January 7, 2019 The company announces that it …
In a new job 1825 Views Modus Therapeutics appoints new CMO Malin Otmani March 15, 2018 The company has appointed Dr. …
Intellectual Property 1940 Views Modus Therapeutics announces two new U.S. patents Malin Otmani November 10, 2016 Modus Therapeutics has been granted …
Intellectual Property 3669 Views Dilaforette change name and announces IPO Malin Otmani October 26, 2016 Dilaforette Holding AB, a clinical-stage …
